title: Antitumor compounds based on a natural product consensus pharmacophore.
abstract: We report the design and highly enantioselective synthesis of a potent analogue of the spliceosome inhibitor FR901464, based on a non-natural product scaffold. The design of this compound was facilitated by a pharmacophore hypothesis that assumed key interaction types that are common to FR901464 and an otherwise unrelated natural product (pladienolide). The synthesis allows for the preparation of numerous novel analogues. We present results on the in vitro activity for this compound against several tumor cell lines.
authors.affiliation: Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
authors.forename: Chandraiah
authors.initials: C
authors.lastname: Lagisetti
authors.forename: Alan
authors.initials: A
authors.lastname: Pourpak
authors.forename: Qin
authors.initials: Q
authors.lastname: Jiang
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Cui
authors.forename: Tinopiwa
authors.initials: T
authors.lastname: Goronga
authors.forename: Stephan W
authors.initials: SW
authors.lastname: Morris
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Webb
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D001685:Biological Factors / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D019556:COS Cells; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002522:Chlorocebus aethiops; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D004852:Epoxy Compounds / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D018942:Macrolides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D051379:Mice; D008958:Models, Molecular; D008968:Molecular Conformation; D041681:NIH 3T3 Cells; D009369:Neoplasms / Q000188:drug therapy*; D011714:Pyrans / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D013141:Spiro Compounds / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D013237:Stereoisomerism
chemical_list: D000970:Antineoplastic Agents; D001685:Biological Factors; D004852:Epoxy Compounds; C104486:FR 901464; D018942:Macrolides; D011714:Pyrans; D013141:Spiro Compounds; C522342:pladienolide B
references.citation: J Antibiot (Tokyo). 1996 Dec;49(12):1196-203
references.pmid: 9031664
references.citation: J Antibiot (Tokyo). 2004 Mar;57(3):188-96
references.pmid: 15152804
references.citation: J Am Chem Soc. 2007 Mar 7;129(9):2648-59
references.pmid: 17279752
references.citation: J Am Chem Soc. 2001 Oct 17;123(41):9974-83
references.pmid: 11592876
references.citation: Bioorg Med Chem. 2004 Apr 15;12(8):1859-66
references.pmid: 15051055
references.citation: Acc Chem Res. 2007 Dec;40(12):1327-39
references.pmid: 18085748
references.citation: J Antibiot (Tokyo). 1997 Jan;50(1):96-9
references.pmid: 9066774
references.citation: Nat Chem Biol. 2007 Sep;3(9):576-83
references.pmid: 17643111
references.citation: Biosci Biotechnol Biochem. 2004 Oct;68(10):2178-82
references.pmid: 15502365
references.citation: J Antibiot (Tokyo). 1996 Dec;49(12):1204-11
references.pmid: 9031665
references.citation: J Org Chem. 2005 Dec 23;70(26):10726-31
references.pmid: 16355992
references.citation: J Am Chem Soc. 2006 Oct 4;128(39):12662-3
references.pmid: 17002356
references.citation: Nat Chem Biol. 2007 Sep;3(9):570-5
references.pmid: 17643112
references.citation: Nat Chem Biol. 2007 Sep;3(9):533-5
references.pmid: 17710096